Evidence map›Paper›PMID 30561643›Full record

ArticleHuman molecular genetics2019

Non-Synonymous variants in premelanosome protein (PMEL) cause ocular pigment dispersion and pigmentary glaucoma.

Adrian A Lahola-Chomiak, Tim Footz, Kim Nguyen-Phuoc, Gavin J Neil, Baojian Fan, Keri F Allen, David S Greenfield, Richard K Parrish, Kevin Linkroum, Louis R Pasquale and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pigment dispersion syndrome and pigmentary glaucoma: overview and racial disparities.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Compound Heterozygous Variants of theFrontiers in genetics · 2022
    Article
  15. From Bench to Bed: The Current Genome Editing Therapies for Glaucoma.Frontiers in cell and developmental biology · 2022
    Review
  16. Melanosome Biogenesis in the Pigmentation of Mammalian Skin.Integrative and comparative biology · 2021
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Adrian A Lahola-ChomiakDepartment of Medical Genetics, University of Alberta, Edmonton AB, Canada.
Tim FootzDepartment of Medical Genetics, University of Alberta, Edmonton AB, Canada.
Kim Nguyen-PhuocDepartment of Medical Genetics, University of Alberta, Edmonton AB, Canada.
Gavin J NeilDepartment of Biological Sciences, University of Alberta, Edmonton AB, Canada.
Baojian FanOcular Genomics Institute and Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
Keri F AllenOcular Genomics Institute and Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
David S GreenfieldDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Palm Beach Gardens, FL, USA.
Richard K ParrishAnne Bates Leach Eye Hospital, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Kevin LinkroumOcular Genomics Institute and Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
Louis R PasqualeOcular Genomics Institute and Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
Ralf M LeonhardtDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Robert RitchEinhorn Clinical Research Center, New York Eye and Ear Infirmary of Mount Sinai, New York, NY, USA.
Shari JavadiyanDepartment of Ophthalmology, Flinders Medical Centre, Adelaide, South Australia, Australia.
Jamie E CraigDepartment of Ophthalmology, Flinders Medical Centre, Adelaide, South Australia, Australia.
W T AllisonDepartment of Medical Genetics, University of Alberta, Edmonton AB, Canada.
Ordan J LehmannDepartment of Medical Genetics, University of Alberta, Edmonton AB, Canada.
Michael A WalterDepartment of Medical Genetics, University of Alberta, Edmonton AB, Canada.
Janey L WiggsOcular Genomics Institute and Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
University of Alberta · CAMassachusetts Eye and Ear Infirmary · USFlinders Medical Centre · AUUniversity of Miami · USNew York Eye and Ear Infirmary · USYale University · US

Funding

P30 Core Grant for Vision ResearchP30EY014104 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Janey L Wiggs · 2002 to 2026
$15.1M
Mechanism of amyloid formation during melanosome biogenesisR21AR068518 · NIAMS · YALE UNIVERSITY · PI LEONHARDT, RALF MAX · 2016 to 2017
$405k
CIHRNEI NIH HHS P30 EY014104NIAMS NIH HHS R21 AR068518
6 · The paper itself

Abstract

Pigmentary glaucoma (PG) is a common glaucoma subtype that results from release of pigment from the iris, called pigment dispersion syndrome (PDS), and its deposition throughout the anterior chamber of the eye. Although PG has a substantial heritable component, no causative genes have yet been identified. We used whole exome sequencing of two independent pedigrees to identify two premelanosome protein (PMEL) variants associated with heritable PDS/PG. PMEL encodes a key component of the melanosome, the organelle essential for melanin synthesis, storage and transport. Targeted screening of PMEL in three independent cohorts (n = 394) identified seven additional PDS/PG-associated non-synonymous variants. Five of the nine variants exhibited defective processing of the PMEL protein. In addition, analysis of PDS/PG-associated PMEL variants expressed in HeLa cells revealed structural changes to pseudomelanosomes indicating altered amyloid fibril formation in five of the nine variants. Introduction of 11-base pair deletions to the homologous pmela in zebrafish by the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 method caused profound pigmentation defects and enlarged anterior segments in the eye, further supporting PMEL's role in ocular pigmentation and function. Taken together, these data support a model in which missense PMEL variants represent dominant negative mutations that impair the ability of PMEL to form functional amyloid fibrils. While PMEL mutations have previously been shown to cause pigmentation and ocular defects in animals, this research is the first report of mutations in PMEL causing human disease.

Indexed as

AdultAmyloidAnimalsExome SequencingFemaleGlaucoma, Open-Anglegp100 Melanoma AntigenHeLa CellsHumansIrisMaleMelanosomesMiddle AgedMutation, MissensePedigreePigmentationAmyloidgp100 Melanoma AntigenPMEL protein, human

Identifiers

PMID30561643
PMCPMC6452206
OpenAlexW2903599363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.